Lv7
5000 积分 2023-12-23 加入
Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade. : 455
7小时前
已完结
Inhibition of a magnesium-sensitive double-stranded RNA clearance machinery boosts cancer immunotherapy
1个月前
已完结
In vivo CRISPR screens identify the glutamine transporter SLC1A5 as a metabolic barrier to antitumor immunity
1个月前
已完结
A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
3个月前
已完结
Single-Cell Spatial Atlas of High-Grade Serous Ovarian Cancer Uncovers MHC Class II as a Key Predictor of Spatial Tumor Ecosystems and Clinical Outcomes
3个月前
已完结
Inhibition of salt-inducible kinases reprograms T cells and antitumor immunity in ovarian cancer
3个月前
已完结
Is Unmutated IgG1 a Wrong Choice for Therapeutic Antibodies Targeting Immune Checkpoints? Lessons From the Clinical Failures of the First Anti–TIGIT Antibodies
3个月前
已关闭
MHC-II-restricted neoantigen vaccine reverses immune microenvironment and overcomes resistance to immune-checkpoint inhibitors in cold tumors
4个月前
已完结
Unleashing T cell surveillance for the eradication of quiescent persister tumor cells resistant to neoadjuvant chemotherapy
4个月前
已完结
皖公网安备34019202002308
